Exclusive-Thousands turn to Wegovy copies each month as FDA considers shortage status

(Reuters) – More than 200,000 prescriptions for copies of Novo Nordisk (NYSE:NVO)’s weight-loss drug Wegovy are getting filled by U.S. patients each …

This post was originally published on this site

Marketing block

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Sign Up for Updates

Get the latest stock market news from Phil by signing up for our newsletter!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Exclusive-Thousands turn to Wegovy copies each month as FDA considers shortage status

Marketing block

Recent Posts

Media Consolidation

What does 2025 hold for interest rates, inflation and the American consumer?

The Future of Syria and Turkey’s Role

Killing the budget bill let China off the hook (shared)

Ranked: The World’s 10 Largest Companies by Revenue

Microsoft Bundling Practices Focus of Federal Antitrust Probe

Sign Up for Updates